Investors and pharmaceutical companies are pouring billions into products aimed at women experiencing menopause. Despite the scale of the business, effective therapies remain in short supply, according to the Handelsblatt archive report summarized here.
The expanding market has attracted attention from companies seeking to benefit from demand for menopause-related products. A German provider is among those profiting from this development.
The report raises questions about whether the billions flowing into the sector are translating into genuinely effective treatment options for women in menopause.
Sources: Handelsblatt.